Neusignal Therapeutics株式会社

Tokyo, JP · 6 known investors

Neusignal Therapeutics develops novel drugs for central nervous system disorders, including dementia and psychiatric conditions, with research focused on calcium signaling in neurons and target discovery for brain diseases. The company serves the pharmaceutical/biotech market and is based in Tokyo, Japan.

BiotechDeep TechDigital HealthMedical Devices